British Patient Capital is the UK government's answer to a persistent market failure: the lack of long-term, patient capital for science and technology scale-ups. Launched in 2018 as a commercial subsidiary of the British Business Bank with an initial £2.5B mandate, it has grown to £3.125B total AUM with £2.3B committed, making it the UK's largest domestic investor in venture and venture growth ca...
London, United Kingdom
London, United Kingdom
Seoul, South Korea
Boston, United States
Liège, Belgium
New York, United States